Blog

Release: Idrasil, Cannabis in a Pill Founder to Exhibit at the Rx for Wealth Symposium April 27 in Huntington Beach

Huntington Beach, April 23, 2013  – Steele C. Smith, III and Medical Director Mark S. Wagner M.D. to exhibit at the Rx for Wealth Network Symposium this Weekend April 27th at the Huntington Beach Hilton.

“We are excited to offer physicians in the concierge field a new tool to bring personal and financial success.  Idrasil, Cannabis in a pill and specifically our physician referral website www.Idrasilrx.com  offers the Dr.’s in the concierge business the ability to raise their visibility and increase patients in their regional markets.” Steele C. Smith, III Founder and Chairman, Idrasil.

Rx for Wealth Network (RXW) is committed to helping doctors offer the best evidence based medicine while keeping up to date with all of the newest technologies and products in today’s growing medical market.

“We are thrilled to have Idrasil as an exhibitor at the symposium, showing once again how the RX Symposium is on the cutting edge of the newest medicine and technologies available to concierge physicians.” Kathy Marks, President, RX for Wealth Network.

RXW prides itself on acting as the conduit, bringing world experts to Physicians to help uncover hidden obstacles that inhibit revenue growth while establishing new ideas to help the practice prosper.

“Idrasil is on the cutting edge of the use of cannabinoids in the prevention of cancer and providing a solution to the over-prescription of opioid pain medication.” Mark S. Wagner M.D.

We are thrilled to join this wonderful symposium as a presenting sponsor, for more information or to be listed on our physician referral website, please visit www.idrasilrx.com or call 855-IDRASIL.

So far, 18 states, as well as the District of Columbia, have legalized the use of medical cannabis and there are several bills currently pending in Congress.

 

Contact:

MEDIA:             George Joyce       831-419-7967
INVESTMENT: Jason Pitkin       714-659-6385

Leave a Reply

Your email address will not be published.